Cargando…

Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study

OBJECTIVE: Despite numerous atypical antipsychotics (AAP) available, many patients with schizophrenia still experience lack of efficacy and persistent side-effects. Switching from one AAP to another with a different side-effect profile has become a common clinical strategy. We aimed to investigate e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yongmin, Wang, Sheng-Min, Kwak, Kyung-Phil, Yoon, Ho-Kyoung, Pae, Chi-Un, Kim, Jung-Jin, Bahk, Won-Myong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083938/ https://www.ncbi.nlm.nih.gov/pubmed/27776390 http://dx.doi.org/10.9758/cpn.2016.14.4.371

Ejemplares similares

Safety and tolerability of antipsychotics: focus on amisulpride
por: Juruena, Mario F, et al.
Publicado: (2010)

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2020)

Clinical Usefulness of Amisulpride Add-on Therapy in Schizophrenia Patients without Treatment Response to Second-generation Antipsychotics
por: Kang, Seung-Gul, et al.
Publicado: (2021)

The use of amisulpride in schizophrenic patients with resistant symptomatology
por: Kalfas, Dimitrios, et al.
Publicado: (2010)

Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2021)

F45. THE EFFICACY AND SAFETY OF BLONASERIN AFTER SWITCHING FROM OTHER ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC INPATIENTS: AN OPEN-LABEL, MULTI-CENTER TRIAL
por: Yoon, Bo-Hyun, et al.
Publicado: (2018)

Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia
por: Kim, Jung-Jin, et al.
Publicado: (2021)

Priapism secondary to antipsychotic treatments with favorable response to amisulpride
por: Pérez Balaguer, A., et al.
Publicado: (2022)

Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?
por: Pae, Chi-Un, et al.
Publicado: (2021)

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting
por: Lee, Kyung Ho, et al.
Publicado: (2023)

Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis
por: Papadopoulou, Dimitra, et al.
Publicado: (2023)

Effectiveness and Tolerability of Korean Red Ginseng Augmentation in Major Depressive Disorder Patients with Difficult-to-treat in Routine Practice
por: Lee, Kyung Ho, et al.
Publicado: (2020)

F194. ASSOCIATION STUDY BETWEEN TREATMENT RESPONSE OF AMISULPRIDE AND DOPAMINE D3 RECEPTOR GENE POLYMORPHISMS
por: Lee, Kwanghun, et al.
Publicado: (2018)

Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study
por: Cascino, Giammarco, et al.
Publicado: (2022)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany
por: Potempa, Christoph, et al.
Publicado: (2018)

Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
por: Pae, Chi-Un
Publicado: (2020)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

The Prevalence of Metabolic Syndrome in Schizophrenic Patients Using Antipsychotics
por: Ko, You-Kyung, et al.
Publicado: (2013)

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
por: Woo, Young Sup, et al.
Publicado: (2022)

Amisulpride induced mania
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Antipsychotic Effects of Quetiapine in Naturalistic Long Term Follow Up Study
por: Lee, Jung-Sun, et al.
Publicado: (2010)

Amisulpride Reexposure and Tardive Dyskinesia
por: Sidana, Ajeet
Publicado: (2018)

Evolution of symptoms with antipsychotic treatment in schizophrenic outpatients in Greece: the GRACE Study
por: Karadima, Dimitra, et al.
Publicado: (2010)

Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs
por: Dogan, Halef Okan, et al.
Publicado: (2018)

Effect of antipsychotic drugs and orthostatic hypotension on the risk of falling in schizophrenic patients
por: Ferinauli, Ferinauli, et al.
Publicado: (2021)

Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study
por: Cicala, Giuseppe, et al.
Publicado: (2020)

Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
por: Srisurapanont, Manit, et al.
Publicado: (2007)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients
por: Suda, Akira, et al.
Publicado: (2018)

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
por: Bahk, W.-M., et al.
Publicado: (2023)

The use of amisulpride in the treatment of acute psychosis
por: Nuss, Philippe, et al.
Publicado: (2007)

Delayed-onset akathisia due to amisulpride
por: Atmaca, Murad, et al.
Publicado: (2011)

Treatment of Burning Mouth Syndrome With Amisulpride
por: Rodriguez-Cerdeira, Carmen, et al.
Publicado: (2012)

Tardive dyskinesia with low dose amisulpride
por: Tharoor, Hema, et al.
Publicado: (2013)

Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
por: Millier, Aurelie, et al.
Publicado: (2011)

Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics
por: Pavăl, Denis, et al.
Publicado: (2018)

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review
por: García, Saínza, et al.
Publicado: (2016)

Efficacy and Tolerability of Aripiprazole: A 26-Week Switching Study from Oral Antipsychotics
por: Lee, Jung-Sun, et al.
Publicado: (2010)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_shurrbkonrd3jr2nlrg1trki8h